Pharma CRDMO revenue forecasts 13-15 per cent growth amid supply-chain derisking EP News Bureau May 9, 2025 Resultant strong cash flows will enable Indian CRDMOs to continue capital expenditure (capex), with limited reliance on debt…
Pharma majors expand US manufacturing amid tariff pressures as BRICS boost biosimilar access,… EP News Bureau Apr 1, 2025 US pharma manufacturing sees investment surge amid tariff shifts, while BRICS nations push regulatory reforms to expand biosimilar…
US tariffs, IP issues threaten patient access Viveka Roychowdhury Apr 1, 2025 The judgements on the Roche Natco case for SMA medicine risdiplam could impact petitions from patients suffering from other rare…
